Feline Toxoplasmosis: Pathogenesis, Neurological Manifestations, Zoonotic Risk, and Prevention

Introduction

Toxoplasma gondii is an obligate intracellular apicomplexan parasite that infects a broad range of warm-blooded vertebrates [1, 2]. Felids, both domestic and wild, serve as the definitive hosts in which the sexual phase of the life cycle occurs [3, 4]. Infection in cats is typically subclinical but can cause overt disease, particularly neurological and ocular manifestations [5]. The parasite is also a major zoonotic pathogen, with oocyst shedding in cat feces representing a primary environmental contamination route [6, 7]. This article provides a detailed examination of the pathogenesis, neurological involvement, zoonotic transmission, and prevention of feline toxoplasmosis, drawing exclusively on a curated set of recent peer-reviewed studies.

Etiology and Life Cycle

T. gondii exists in three infectious stages: tachyzoites, bradyzoites (within tissue cysts), and sporozoites (within oocysts) [3, 4]. The sexual cycle is restricted to the feline intestinal epithelium, where merozoites undergo gametogony and fertilization to produce unsporulated oocysts [4, 8]. A single-cell atlas of sexual development in the feline gut has revealed previously uncharacterized transcriptional programs driving this process [4]. After excretion, oocysts sporulate in the environment and become infective [6]. Pre-sexual stages exhibit distinct cell division patterns, characterized by endopolygeny and asynchronous nuclear division [3]. Domestic cats acquire infection by ingesting tissue cysts from intermediate hosts (e.g., rodents, birds) or by ingesting sporulated oocysts from contaminated soil or water [2, 7].

Epidemiology

Seroprevalence of T. gondii in cats varies geographically. Studies in Hong Kong reported seroprevalence rates of 25.1% in privately owned cats and 38.4% in community cats, with risk factors including age and outdoor access [2]. In Jordan, seroprevalence reached 41.3%, with molecular detection of parasite DNA in feces confirming active shedding [7]. In Bangladesh, genotype distribution analysis showed a predominance of type II and III strains in domestic animals, including cats [9]. Wildlife also serves as a sentinel for environmental contamination; nonhuman primates and wild felids in Brazilian zoos exhibited seropositivity rates exceeding 60% [10]. A systematic review of T. gondii in Chinese wildlife (1985–2024) identified 77 species as intermediate hosts, emphasizing the broad zoonotic reservoir [11]. Livestock such as goats, sheep, and cattle frequently exhibit high seroprevalence, particularly in regions with free‑ranging cats [12, 13, 14]. Aborted fetuses in goats and horses have yielded PCR‑positive results, linking infection to reproductive failure [15, 13]. Migratory birds also carry the parasite and may disseminate oocysts over long distances [16].

Pathogenesis and Neurological Manifestations (Cat Toxoplasmosis Brain)

After ingestion, T. gondii crosses the intestinal epithelial barrier and disseminates hematogenously [8]. The parasite preferentially invades neural and muscle tissues, forming latent bradyzoite cysts [17, 5]. Reactivation in immunocompromised cats leads to tachyzoite proliferation and focal encephalitis [17]. The term “cat toxoplasmosis brain” refers to cerebral inflammation caused by active tachyzoite replication in the central nervous system (CNS). Histopathological findings include multifocal gliosis, perivascular cuffing, and necrotic foci containing free tachyzoites and cysts [17]. In a renal transplant recipient with cerebral toxoplasmosis, imaging revealed ring‑enhancing lesions in the basal ganglia [17]; analogous pathology occurs in immunosuppressed cats. A population‑based cohort study in humans linked childhood T. gondii seropositivity to reduced grey matter volume and increased psychotic experiences, suggesting long‑lasting neuroanatomical effects [18]. In cats, neurological signs include altered behavior, seizures, ataxia, head pressing, and cranial nerve deficits [17, 5]. The microneme protein MIC17A has been identified as a promising marker for entero‑epithelial and chronic stages, facilitating detection of both acute and latent CNS infection [5].

Neurological Manifestations in Feline Clinical Cases

Clinical toxoplasmosis in cats most frequently involves the CNS, eyes, or respiratory system [5, 7]. Ocular presentations include anterior uveitis, chorioretinitis, and optic neuritis [19, 20]. Neurological signs may result from both direct parasitic invasion and secondary inflammatory responses [17, 18]. Diagnosis of cerebral toxoplasmosis relies on detection of anti‑T. gondii IgM/IgG in cerebrospinal fluid or identification of bradyzoites in brain biopsies [5]. Anti‑sense PCR assays have shown high sensitivity for detecting T. gondii DNA in feline tissues, including brain [21].

Zoonotic Risk and Oocyst Shedding (Toxoplasmosis in Cat Poop)

Toxoplasmosis in cat poop constitutes the primary source of environmental contamination [6, 7]. A single cat can shed millions of oocysts over 1–2 weeks, and oocysts remain infective for months in moist soil [6]. A study in Bangkok detected T. gondii DNA in 8.3% of fecal samples from stray cats, confirming ongoing environmental shedding [6]. Seropositive cats from a neutering program in Brazil also harbored parasite DNA in reproductive tissues, suggesting a potential role for vertical transmission [22]. Oocysts are resistant to many disinfectants and can be inadvertently ingested by intermediate hosts, including humans, through contaminated food or water [1, 12]. In urban informal settlements in Brazil, social marginalization and environmental degradation were associated with higher T. gondii exposure [1]. Veterinary professionals and students are at increased risk of seropositivity compared to the general population, underscoring occupational hazard [23]. Pregnant women seronegative for toxoplasmosis are advised to avoid cleaning litter boxes; educational interventions in Côte d’Ivoire and Erbil have shown gaps in knowledge about transmission routes [24, 25, 26]. Congenital transmission can occur if a woman acquires primary infection during pregnancy [27, 26].

Diagnostic Approaches

Diagnosis of feline toxoplasmosis relies on serological, molecular, and histopathological methods. Serological detection of IgG and IgM antibodies is commonly performed using commercial ELISA kits or rapid immunochromatographic strips [28, 29]. A double‑antigen sandwich colloidal gold strip developed for multiple host species showed high sensitivity and specificity for field use [28]. A SAG1‑based strip specifically optimized for swine also demonstrated utility for cross‑species application [29]. Molecular detection by conventional PCR or real‑time PCR targets the B1 gene or 529‑bp repeat element. Fecal PCR from stray cats in Thailand yielded a detection rate of 8.3% [6]. An antisense PCR assay developed for domestic cats improved specificity by targeting complementary RNA transcripts [21]. Histological examination of brain or muscle tissue can reveal cysts and tachyzoites, with immunohistochemistry confirming the presence of T. gondii antigen [13]. The following table summarizes the main diagnostic modalities:

Treatment

Antiparasitic therapy is indicated for cats with clinical toxoplasmosis, particularly those exhibiting neurological or ocular signs. The combination of clindamycin (a lincosamide antibiotic) with pyrimethamine and sulfadiazine (a dihydrofolate reductase inhibitor plus sulfonamide) is the standard regimen. Clindamycin alone is effective for CNS disease due to its blood‑brain barrier penetration. Treatment duration typically extends for 2–4 weeks, and clinical improvement should be monitored. In immunocompromised cats, lifelong suppressive therapy may be required to prevent reactivation.

Prevention and Control

Prevention of feline toxoplasmosis targets both the cat as a source of oocyst shedding and the intermediate host (including humans) to reduce exposure. Management strategies include:

• Confining cats indoors to prevent hunting of infected prey [2, 7].
• Feeding only cooked or commercial diets to avoid ingestion of tissue cysts [12].
• Daily removal of feces from litter boxes, as oocysts require 1–5 days to sporulate and become infective [6].
• Proper litter box hygiene: use gloves, wash hands thoroughly, and disinfect with ammonia or boiling water.
• Avoiding contamination of vegetable gardens and sandboxes with cat feces [1, 26].

Vaccination is a promising avenue for long‑term control. Gene‑edited live‑attenuated vaccines have been developed by deleting key virulence genes (e.g., ROP18, MIC1), conferring protection against challenge in murine models [30]. A review of antigen discovery strategies highlighted the potential of mRNA vaccines, particularly those targeting surface antigens SAG1 and SAG2, combined with One Health approaches [31]. However, no licensed vaccine for cats is currently available in most countries.

One Health Perspectives

Given that T. gondii circulates among cats, wildlife, livestock, and humans, integrated control measures are essential [31, 12, 10]. Educational campaigns targeting pregnant women and immunocompromised individuals have improved knowledge about zoonotic risks [24, 25]. In addition, environmental monitoring of oocyst contamination in soil and water can inform public health interventions [1, 6]. A Mermaid flowchart below summarizes the transmission pathways and intervention points.

flowchart TD
    A[Infected cat], >|Oocysts in feces| B[Environment: soil, water, litter box]
    B, >|Ingestion by intermediate host| C[Rodents, birds, livestock]
    C, >|Tissue cysts| D[Predation / raw diet]
    D, > A
    B, >|Ingestion by humans| E[Zoonotic infection]
    E, > F[Humans: pregnant, immunocompromised]
    B, >|Ingestion by cats| A
    A, >|Direct contact| G[Veterinary professionals]
    G, >|Occupational exposure| E
    style A fill:#f9f,stroke:#333,stroke-width:2px
    style E fill:#f96,stroke:#333,stroke-width:2px

Conclusion

Feline toxoplasmosis remains a significant concern for animal health and public health. The parasite’s ability to persist in neural tissues underlies a spectrum of neurological manifestations in cats, while oocyst shedding in feces perpetuates environmental contamination. Recent advances in molecular diagnostics, including antisense PCR and immunochromatographic strips, have improved detection sensitivity in field settings. Vaccine development using gene editing and mRNA platforms holds promise for reducing shedding in cats. A One Health approach integrating veterinary, environmental, and human health measures is essential to mitigate the zoonotic risk posed by T. gondii.

References

[1] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330015/

[2] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[3] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/

[4] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/

[5] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/

[6] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/

[7] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/

[8] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/

[9] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41528989/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[10] Andrade ACS, Vieira FPR, Dos Santos IC, et al. Nonhuman Primates and Wild Felines as Environmental Bioindicators of Toxoplasma gondii and Leishmania spp. from a Brazilian Zoo. Vector Borne Zoonotic Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41879174/

[11] Zhu XK, Cong W, Meng QF. Toxoplasma gondii infection in wildlife in China (1985-2024): A systematic review and meta-analysis with machine learning. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41747478/

[12] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/

[13] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864556/

[14] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819961/

[15] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252005/

[16] Tsakmakidis I, Moustakidis K, Alvanou MV, et al. Migratory and opportunistic wild and domestic birds, as Toxoplasma gondii carriers. Parasite Epidemiol Control. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41970607/

[17] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/

[18] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41643571/

[19] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41603939/

[20] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41597614/

[21] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/

[22] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651631/

[23] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/

[24] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/

[25] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41873025/

[26] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/

[27] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/

[28] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253330/

[29] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/

[30] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252477/

[31] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/

[32] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034957/

[33] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931585/

[34] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/

[35] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741032/